|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
8
|
Resverlogix Corp.
|
Aug 12, 2019 09:50AM
|
|
Re: No mention of efficacy again...
|
8
|
Resverlogix Corp.
|
Mar 29, 2019 02:13PM
|
|
Re: sounds like a lonely someone needs a hug ..
|
8
|
Resverlogix Corp.
|
Jun 17, 2020 08:52AM
|
|
Re: Now that we're a small cap stock....
|
8
|
Resverlogix Corp.
|
Jul 12, 2018 12:10PM
|
|
Re: Wow! Quite the read!
|
8
|
Resverlogix Corp.
|
May 30, 2021 07:48PM
|
|
BD-selectivity vs. BET protein selectivity
|
8
|
Resverlogix Corp.
|
Oct 05, 2018 10:25AM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
8
|
Resverlogix Corp.
|
Jul 08, 2019 09:36AM
|
|
A birthday present for DM?
|
8
|
Resverlogix Corp.
|
Aug 20, 2019 03:46PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
8
|
Resverlogix Corp.
|
Dec 02, 2019 10:32AM
|
|
Re: BETonMACE top line data
|
8
|
Resverlogix Corp.
|
Jan 17, 2018 11:35PM
|
|
Re: My guess is a second BTD is coming
|
8
|
Resverlogix Corp.
|
Feb 08, 2020 11:04AM
|
|
Re: Would they release any info
|
8
|
Resverlogix Corp.
|
Sep 30, 2019 10:07AM
|
|
Re: Risk vs Reward moving forward!
|
8
|
Resverlogix Corp.
|
Dec 17, 2021 02:32PM
|
|
Re: ... AGM thoughts...
|
8
|
Resverlogix Corp.
|
Nov 28, 2017 12:39PM
|
|
Top-Line, Primary Outcomes, Secondary Outcomes, Exploratory Outcomes, and Alzheimer's/Cognitio...
|
8
|
Resverlogix Corp.
|
Jul 12, 2018 02:37PM
|
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 23, 2016 11:24PM
|
|
Re: Bear
|
8
|
Resverlogix Corp.
|
Jan 13, 2020 05:34PM
|
|
Re: Booyah ! I told you all!!
|
8
|
Resverlogix Corp.
|
May 15, 2019 11:11PM
|
|
Re: Where is BDAZ?
|
8
|
Resverlogix Corp.
|
May 15, 2021 12:41PM
|
|
ACC/WCC 2020
|
8
|
Resverlogix Corp.
|
Dec 25, 2019 06:34PM
|
